Bringing Groundbreaking Treatments to Patients with Psychiatric and Neurodegenerative Diseases

Unleashing unique properties and biological effects of Noble gases for treatment of PTSD, Autism, Dementia

Combining revolutionary portable inhalation device with a safe therapeutic

Accelerated pathway of clinical development

Nobilis Therapeutics is developing proprietary inhalation-based therapeutics using controlled self-administration of inert gases to address unmet medical need in the treatment of psychiatric and neurodegenerative diseases.

By leveraging data on more than 500 patients successfully treated for conditions ranging from panic disorder to autoimmune diseases, Nobilis has coupled its patent pending gas mixtures with a proprietary inhalational device to offer reproducible, standardized, and controlled patient exposure. The Company is currently advancing its technologies into human clinical trials.

News Feed

Twitter Feed

Nobilis Therapeutics @NobilisTx
Sex-Specific Regulation of Fear Memory by Targeted Epigenetic Editing of <em>Cdk5</em> https://t.co/zNxGcmuABN
h J R
Nobilis Therapeutics @NobilisTx
Nobilis Therapeutics Enters Into Collaboration With The Linde Group to Support Its Clinical Research Program to Stu… https://t.co/5rWCHl3waf
h J R
Nobilis Therapeutics @NobilisTx
Yet another reason for NBTX-001 to be effective in PTSD as it reduces IL and TNF-Alfa by >50%. https://t.co/TWAX1FTvO6
h J R
Nobilis Therapeutics @NobilisTx
This supports our previous findings and our IP. The only disagreement is on the description of xenon as a “weak” NM… https://t.co/k1YepmHwmh
h J R